Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2006 2
2007 3
2008 1
2009 2
2010 2
2011 3
2012 2
2013 5
2014 5
2016 2
2017 10
2018 10
2019 5
2020 7
2021 6
2022 6
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Compelling Story of Ovarian Cancer Screening.
Pavlik EJ, van Nagell JR Jr, Dietrich CS 3rd, Ueland FR. Pavlik EJ, et al. Among authors: ueland fr. J Clin Oncol. 2024 Apr 1;42(10):1091-1094. doi: 10.1200/JCO.23.02424. Epub 2024 Feb 2. J Clin Oncol. 2024. PMID: 38306587 No abstract available.
Gynecologic laparoscopy.
Desimone CP, Ueland FR. Desimone CP, et al. Among authors: ueland fr. Surg Clin North Am. 2008 Apr;88(2):319-41, vi. doi: 10.1016/j.suc.2007.12.008. Surg Clin North Am. 2008. PMID: 18381116 Review.
Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies.
Wei Y, Erfani S, Schweer D, de Gouvea R, Qadir J, Shi J, Cheng K, Wu D, Craven R, Wu Y, Olivier T, Baldwin LA, Zhou B, Zhou Y, Zhao W, Yang BB, Ueland FR, Yang XH. Wei Y, et al. Among authors: ueland fr. Mol Ther Oncolytics. 2023 Feb 19;28:293-306. doi: 10.1016/j.omto.2023.02.006. eCollection 2023 Mar 16. Mol Ther Oncolytics. 2023. PMID: 36911068 Free PMC article. Review.
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).
Arend RC, Monk BJ, Shapira-Frommer R, Haggerty AF, Alvarez EA, Amit A, Alvarez Secord A, Muller C, Casado Herraez A, Herzog TJ, Tewari KS, Cohen JG, Huang M, Yachnin A, Holeman LL, Ledermann JA, Rachmilewitz Minei T, Buyse M, Fain Shmueli S, Lavi M, Harats D, Penson RT; OVAL/GOG-3018 Investigators. Arend RC, et al. J Clin Oncol. 2024 Jan 10;42(2):170-179. doi: 10.1200/JCO.22.02915. Epub 2023 Oct 31. J Clin Oncol. 2024. PMID: 37906726 Clinical Trial.
First International Consensus Report on Adnexal Masses: Management Recommendations.
Glanc P, Benacerraf B, Bourne T, Brown D, Coleman BG, Crum C, Dodge J, Levine D, Pavlik E, Timmerman D, Ueland FR, Wolfman W, Goldstein SR. Glanc P, et al. Among authors: ueland fr. J Ultrasound Med. 2017 May;36(5):849-863. doi: 10.1002/jum.14197. Epub 2017 Mar 7. J Ultrasound Med. 2017. PMID: 28266033
79 results